Can cholesteryl ester transfer protein inhibitors reduce incident type 2 diabetes?
Read More »Vascular Disease Is A Significant Concern for Patients with Diabetes
Adults who have diabetes are two times more likely to die from heart disease and stroke, and younger people with diabetes are at risk of earlier heart disease.
Read More »Reducing Cardiovascular Disease in Patients with Type 1 Diabetes
Patients with type 1 diabetes should not be excluded when considering statin therapy.
Read More »Gender Affects Vascular Disease Associated with Diabetes
How adipose tissue storage, which differs by gender, plays a role in the development and treatment of the disease.
Read More »Prediabetes Equals Diabetes
Current studies are showing that micro and macro complications begin at prediabetes.
Read More »A1C levels are Indicators of Coronary Atherosclerotic Plaque Formation
Coronary atherosclerotic plaques can be identified early, but specific risk factors are not fully understood.
Read More »Cortisol Levels in Patients with Obesity Predict Hypertension and Diabetes
Researchers may have found a new way to detect hypertension and diabetes in people with obesity: an alteration in the hypothalamic-pituitary-adrenal (HPA) axis.
Read More »Prevalence of Type 2 Diabetes in Genetic Dyslipidemia
Examining risk for type 2 in patients with genetic dyslipidemia conditions.
Read More »Best Practices for Treating Comorbidities in Patients with COVID-19
Patients with diabetes and hypertension may be affected differently in COVID-19 infections.
Read More »Update on Rosiglitazone and its Complications
Will the discovery of more adverse effects of rosiglitazone lead to its suspension in the US?
Read More »